Delivery Order SPE2DB22D3501-SPE2DB25FXC81
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 2, 2025, by the Defense Logistics Agency to supply Rotarix vaccine in oral syringe format (1.5 mL) with a contract ceiling value of $14,439.40. This firm fixed-price delivery order represents a non-set-aside competitive award with an ultimate completion date of September 3, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,429.98 to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5ML) on August 28, 2025, with an ultimate completion date of August 29, 2025. This non-set-aside, firm fixed price delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $19,843.69 for Rotarix vaccine oral syringes (1.5 mL) with a completion date of July 30, 2025. This competitive award, issued on July 29, 2025, carries firm fixed-price terms and involves no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Rotarix Vaccine Oral Syringe 1.5ML with a ceiling value of $14,065.80. This firm fixed price delivery order, which is expected to be completed by August 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The contract was competitively...
- The Defense Logistics Agency awarded a $2,214.99 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for Rotarix vaccine oral syringes (1.5mL). This non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,654.02 firm fixed-price contract is for the delivery of the ROTARIX vaccine oral syringes (1.5 mL) and has an ultimate completion date of October 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency awarded a delivery order valued at $6,644.97 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine in oral syringe format (1.5 milliliter units). This firm fixed-price delivery order, executed on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a $31.3K firm fixed price delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5ml) with an ultimate completion date of September 3, 2025. This competitively awarded, non-set-aside contract reflects AmerisourceBergen's ongoing role as a critical pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery order was performed at...
- The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $10,268.58 for the provision of ROTARIX vaccine oral syringes. The award has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor, and this order is fulfilled under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp valued at up to...
- The Defense Logistics Agency awarded a delivery order valued at $1,476.68 to AmerisourceBergen Drug Corp for the supply of Rotarix Vaccine Oral Syringe 1.5ML, with an ultimate completion date of August 14, 2025. The award was made on August 13, 2025, using firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXC81Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,696.28 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Rotarix vaccine oral syringes in 1.5ml quantities. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 3, 2025, and was competitively awarded with no set-aside designation. This award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor and healthcare solutions provider for federal military and veteran healthcare systems, with an extensive portfolio of medical product deliveries across multiple therapeutic domains. The company's role as a prime vendor for DLA Medical Supply Chain enables it to supply vaccines, medications, syringes, and other specialized medical commodities to support military healthcare programs globally. This delivery order for Rotarix vaccine reflects the company's ongoing capability to fulfill federal medical procurement requirements for the Defense Health Agency and other government healthcare systems through its comprehensive contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 9/2/25 |